The Swedish laboratory Ferring has sold the Dupomar line, which they had acquired ten years before, to the national company Investi.
The Swedish laboratory Ferring has sold the Dupomar line, which they had acquired ten years before, to the national company Investi.
The $ 4 million deal comprises the sale of Calcio Base Dupomar, Citramar, Deltrox, Filotricin, Mar-V and Piroxicam.
The transaction also includes the transfer of 15 medical advertising agents from Ferring to Investi, a laboratory that specializes in women’s health and that belongs to Roemmers.
Ferring will now be focused on its infertility line, the growth hormone, gastroenterology, and gynecology. It has also created a team that will work on public and private social security.
None of the companies wanted to talk with Pharmabiz about this deal.
It is striking that Ferring has not issued any global press release. It may have chosen not do so because Dupomar is a local and regional line.
Nevertheless, in 2004, the Swedish laboratory announced with great fanfare its purchase of Dupomar to national businessmen. See press release.
